A BuiltForAI Property
Live data · NADAC + Part D CY24 · reviewed daily

Sufentanil (Dsuvia)

Sufentanil relieves moderate to severe pain by acting on opioid receptors in the brain.

First FDA approval2005-07-26
Generic availableYes · 2 mfrs
Shortage statusActive shortage
340B exposureunknown
Last updated
NADAC: weekly (every Wed)Part D Formulary: quarterlyPart D Spend: annual (CY24)Orange Book: weeklyShortages: daily
At a glance · the numbers a plan sponsor wants on screen one
Lowest NADAC
/unit
0 NDCs benchmarked, lowest of all strengths.
Average NADAC
Across all dosage forms in distribution.
Highest NADAC
Range is tight.
Plans with PA
0 / 329
Zero PA friction — switching is purely formulary.

Questions a plan sponsor actually asks.

FAQPage schema10 entries indexed · 4 visible
What is Sufentanil used for?

Sufentanil relieves moderate to severe pain by acting on opioid receptors in the brain.

Is there a generic for Sufentanil?

Yes. 2 ANDAs filed at FDA, 2 generic manufacturers currently shipping.

How much does my plan pay for Sufentanil?

NADAC pricing data not currently available for this drug.

Is Sufentanil on the FDA shortage list?

Yes. Sufentanil is currently listed as an active FDA shortage.

6 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.

Same class. Different math.

Opioid Agonist6 alternatives in D1
01
Fentanyl
Brand: Fentanyl system
$1.24Lowest NADAC
5Generic mfrs
$139.6MCY24 Part D spend
Compare →
02
Fentanyl Transdermal
Opioid Agonist
$5.69Lowest NADAC
0Generic mfrs
CY24 Part D spend
Compare →
03
Hydrocodone Bitartrate and Homatropine Methylbromide
Brand: Hycodan
$0.098Lowest NADAC
6Generic mfrs
CY24 Part D spend
Compare →
04
Hydrocodone and Apap
Brand: Norco
Lowest NADAC
0Generic mfrs
CY24 Part D spend
Compare →
05
Hydromorphone
Brand: Dilaudid
$0.166Lowest NADAC
8Generic mfrs
$28.7MCY24 Part D spend
Compare →
06
Levorphanol
Opioid Agonist
$10.65Lowest NADAC
5Generic mfrs
$20.6MCY24 Part D spend
Compare →

Sources · every number above traces back.

Last refresh30 May 2026

Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book (3 approvals on file) · NADAC unit costs: CMS NADAC weekly file · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.